Roadshow
API for New Drug development
FB-1603
A natural microalgae-derived active ingredient with anti-inflammatory and antioxidant potential. It has obtained a U.S. FDA DMF (034864).
FB-1807
A novel orally available small molecule candidate for liver fibrosis/cirrhosis
Join us at BIO 2026, June 22–25 in San Diego!
Taipei’s biotech innovators will showcase cutting-edge solutions and services at the Taiwan Pavilion. Visit Booth #2621 to explore partnership opportunities, meet leading Taipei companies, and discover how Taipei is advancing the future of biotechnology.
Let’s connect at BIO 2026 — see you in San Diego!
#BIO2026 #Taipei #TaiwanPavilion
FB-1603
FB-1603 is a natural microalgae-derived active ingredient candidate with demonstrated anti-inflammatory and antioxidant activities in multiple liver injury animal models. With a U.S. FDA Drug Master File (DMF 034864) in place, FB-1603 is currently supplied to biomedical partners for Phase II clinical development in acute hepatitis, supporting its potential for further pharmaceutical and partnership development.
FB-1807
FB-1807 is a novel orally available small molecule candidate for liver fibrosis. It demonstrates anti-fibrotic activity through a new mechanism of action, with preliminary animal data indicate favorable safety and oral absorption potential.
- #FEBICO
- #pharmaceutical partnership
- #drug development
- #active pharmaceutical ingredient
- #FB-1603
- #liver injury
- #U.S. FDA DMF
- #FB-1807
- #liver fibrosis candidate
- Established 1990
- Company Far East Bio-Tec. Co., Ltd.
- Telephone 886-2-2655-8198
- Email info@febico.com
- Address Room A, 13F. No.3 Yuan Chiu Street, Nangang District, Taipei 115, Taiwan
FEBICO is committed to providing the highest-quality microalgae superfoods and becoming a leading global brand in microalgae biotechnology. With nearly 50 years of expertise in microalgae production, FEBICO is a leading global producer of organic spirulina, organic chlorella, natural spirulina, natural chlorella, and nutritional supplements. The company has earned an international reputation for high-quality, pure spirulina and chlorella products backed by reliable production capabilities.
Beyond microalgae superfoods, FEBICO continues to expand its biotechnology applications through innovative products, including algal fluorescent proteins for virus and antibody detection, Apogina skincare products derived from nutrient-rich microalgae extracts, and novel cell culture supplements such as MSEP-01 and SHWE-HSB, designed to reduce reliance on animal serum while maintaining cell viability. In medical applications, FEBICO has also identified novel active ingredients with antiviral and hepatoprotective potential, providing active pharmaceutical ingredients and technical support for new drug development.